These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1911122)

  • 1. How safe is the treatment of uraemic children with recombinant human growth hormone?
    Tönshoff B; Heinrich U; Mehls O
    Pediatr Nephrol; 1991 Jul; 5(4):454-60. PubMed ID: 1911122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.
    Tönshoff B; Schaefer F; Mehls O
    Pediatr Nephrol; 1990 Nov; 4(6):654-62. PubMed ID: 2088470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate.
    Tönshoff B; Tönshoff C; Mehls O; Pinkowski J; Blum WF; Heinrich U; Stöver B; Gretz N
    Eur J Pediatr; 1992 Aug; 151(8):601-7. PubMed ID: 1380459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.
    Maxwell H; Nair DR; Dalton RN; Rigden SP; Rees L
    Pediatr Nephrol; 1995 Aug; 9(4):458-63. PubMed ID: 7577409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.
    Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; Di Nero G
    J Pediatr; 1993 Jan; 122(1):37-45. PubMed ID: 8419613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of growth hormone treatment in GH-deficient adults.
    Jørgensen JO; Pedersen SA; Thuesen L; Jørgensen J; Ingemann-Hansen T; Skakkebaek NE; Christiansen JS
    Lancet; 1989 Jun; 1(8649):1221-5. PubMed ID: 2566779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma growth hormone-binding activity is low in uraemic children.
    Postel-Vinay MC; Tar A; Crosnier H; Broyer M; Rappaport R; Tönshoff B; Mehls O
    Pediatr Nephrol; 1991 Jul; 5(4):545-7. PubMed ID: 1911135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose metabolism in chronic renal failure with reference to GH treatment of uremic children.
    Schmitz O; Orskov L; Lund S; Møller N; Christiansen JS; Orskov H
    J Pediatr Endocrinol; 1993; 6(1):53-9. PubMed ID: 8374690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
    Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic clearance rate of biosynthetic growth hormone after endogenous growth hormone suppression with a somatostatin analogue in chronic renal failure patients and control subjects.
    García-Mayor RV; Pérez AJ; Gandara A; Andrade A; Mallo F; Casanueva FF
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):337-43. PubMed ID: 8222296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency.
    Seminara S; Merello G; Masi S; Filpo A; La Cauza F; D'Onghia G; Martelli E; Loche S
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):125-30. PubMed ID: 9797856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels of soluble CD30 are increased in children with chronic renal failure and with primary growth deficiency and decrease during treatment with recombination human growth hormone.
    Barbano G; Cappa F; Prigione I; Pistoia V; Cohen A; Chiesa S; Gusmano R; Perfumo F
    Nephrol Dial Transplant; 2001 Sep; 16(9):1807-13. PubMed ID: 11522862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of long-term continuous growth hormone treatment of children born small for gestational age.
    Hokken-Koelega A; van Pareren Y; Arends N; Boonstra V
    Horm Res; 2004; 62 Suppl 3():149-54. PubMed ID: 15539818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.
    Low LC; Kwan EY; Lim YJ; Lee AC; Tam CF; Lam KS
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):359-63. PubMed ID: 7750189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications of growth hormone therapy in children.
    Blethen SL
    Curr Opin Pediatr; 1995 Aug; 7(4):466-71. PubMed ID: 7581653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth.
    Ritz E; Tönshoff B; Worgall S; Kovacs G; Mehls O
    Pediatr Nephrol; 1991 Jul; 5(4):509-12. PubMed ID: 1911130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. The German Study Group for Growth Hormone Treatment in Chronic Renal Failure.
    Tönshoff B; Cronin MJ; Reichert M; Haffner D; Wingen AM; Blum WF; Mehls O
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1007-13. PubMed ID: 9100565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of short stature in renal disease with recombinant human growth hormone.
    Rees L; Rigden SP; Ward G; Preece MA
    Arch Dis Child; 1990 Aug; 65(8):856-60. PubMed ID: 2400222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for recombinant growth hormone (rhGH) treatment in kidney diseases].
    Colombo D; Ghio L; Marchesi F; Giani M; Carcano A; Consalvo G; Edefonti A
    Pediatr Med Chir; 1995; 17(1):17-22. PubMed ID: 7739921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.